Acessibilidade / Reportar erro

Dermoscopy of inflammatory breast cancer* * Work performed at the Dermatology Service of Hospital Alemán, Buenos Aires, Argentina.

Abstract:

Inflammatory breast cancer is an aggressive and infiltrative malignancy that is often misdiagnosed as an infection because of its symptoms and signs of inflammation, delaying proper diagnosis and treatment. We report a case of inflammatory breast cancer showing correlation between dermoscopic and histopathological diagnoses. We highlight the utility of dermoscopy for skin biopsy site selection.

Keywords:
Breast neoplasms; Dermoscopy; Inflammatory breast neoplasms

A 46-year-old woman with personal history of schizophrenia consulted for an erythematous plaque with diffuse borders covered by grouped translucent papular lesions and some rounded erosions on the inferior and external aspects of the left breast for 6-months (Figure 1). She had been using topical antibiotics and steroids on the lesions for months without medical prescription. Physical examination revealed an underlying 4-cm indurated nodule on the lower portion of the breast and other nodules of similar characteristics on the left axilla.

Figure 1
Inflammatory breast cancer. Clinical presentation

Dermoscopy showed multiple grouped white-to-yellow rounded milia-like cysts over an erythematous background and irregular linear vessels over and between them (Figure 2). A skin biopsy of one of these milia-like cysts was performed. Microscopic examination showed multiple dermal intralymphatic emboli of a primary comedo-type ductal breast carcinoma (inflammatory carcinoma). Therefore, we reached the diagnosis of inflammatory breast cancer (IBC) (Figure 3).

Figure 2
Inflammatory Breast Cancer. Dermoscopic features. Original magnification: X10

Figure 3
Inflammatory Breast Cancer. Histologic diagnosis. (Hematoxylin & eosin,A - X100 and B - X400)

Breast nodules and axilla lymph nodes were biopsied confirming the diagnosis of invasive ductal carcinoma of the left breast with axillary lymph node involvement. Both samples were positive for hormone receptors and negative for human epidermal growth factor receptor 2 (HER2). Computed tomography revealed lung and liver metastasis. Systemic chemotherapy consisting of doxorubicin and cyclophosphamide was indicated.

IBC is a rare and very aggressive type of locally advanced breast cancer with a poor prognosis.11 Il'yasova D, Siamakpour-Reihani S, Akushevich I, Akushevich L, Spector N, Schildkraut J. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma? Breast Cancer Res Treat. 2011;130:691-7.,22 Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-75. Patients present with rapid onset of erythema and edema of the breast skin (peau d'orange).22 Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-75. Because of its clinical signs and symptoms, sometimes IBC is misdiagnosed as a bacterial infection. It also may be misdiagnosed as mastitis, abscess of the breast, metastasis from another cancer, postradiation dermatitis, or even breast edema from congestive heart failure. Presumptive diagnosis of cellulitis or mastitis and treatment with a trial of antibiotic therapy is the leading cause of delay in diagnosis and treatment of IBC and can be deadly.33 Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, et al. Inflammatory Breast Cancer: What We Know and What We Need to Learn. Oncologist. 2012;17:891-9.

Minimum criteria required for the diagnosis of IBC include the following: rapid onset of breast erythema, edema and/or peau d'orange, and/or warm breast, with or without an underlying palpable mass; duration of history of no more than 6 months; erythema occupying at least one-third of the breast; and pathological confirmation of invasive carcinoma.44 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23.

The inflammatory skin changes of a breast afflicted with IBC represents the presence of dermal lymphatic invasion (DLI), a state in which dilated dermal lymphovascular spaces are filled with tumor emboli that are often retracted away from the surrounding endothelial lining.44 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23.,55 Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, et al. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. Int J Cancer. 2013;132:2283-94. Considered to be a histological hallmark of IBC, DLI subsequently leads to lymphatic obstruction and is ultimately responsible for the highly metastatic potential of IBC.44 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23.,55 Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, et al. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. Int J Cancer. 2013;132:2283-94. Therefore, although pathological evidence of dermal lymphatic involvement is not considered a definitive diagnostic criterion for IBC, it is strongly recommend that every patient who meets the diagnostic criteria for IBC undergo at least two skin punch biopsy.44 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23. This helps not only determining the presence of DLI but will also help in confirming the diagnosis of an invasive carcinoma in the absence of an underlying intraparenchymal lesion or regional metastases.44 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23.

As shown in the present case, the milia-like cysts revealed by dermoscopy correlated with DLI. Therefore, the identification of these dermoscopic structures, when present, could be an aid for accurate clinical diagnosis and also a useful guide for skin biopsy, avoiding sampling errors.

To the best of our knowledge, this is the first report that describes the clinical-dermoscopic-histopathological correlation of the DLI characteristic of IBC.

  • *
    Work performed at the Dermatology Service of Hospital Alemán, Buenos Aires, Argentina.
  • Financial support: None

REFERENCES

  • 1
    Il'yasova D, Siamakpour-Reihani S, Akushevich I, Akushevich L, Spector N, Schildkraut J. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma? Breast Cancer Res Treat. 2011;130:691-7.
  • 2
    Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-75.
  • 3
    Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, et al. Inflammatory Breast Cancer: What We Know and What We Need to Learn. Oncologist. 2012;17:891-9.
  • 4
    Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515-23.
  • 5
    Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, et al. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. Int J Cancer. 2013;132:2283-94.

Publication Dates

  • Publication in this collection
    Mar-Apr 2018

History

  • Received
    15 Dec 2016
  • Accepted
    20 Feb 2017
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br